This is a fantastic firm operating in a growing industry. They get recurring royalties on their Abs used in diagnostic test. This industry is growing rapidly and gives investors in a small cap the exposure (indirectly) to the global healthcare market. Dividend is solid and hte only major issues are IP protection, a concentration of talent in a limited pool of staff and liquidity of shares.
Major dump has led to a huge price increase,this doesn't seem to fit for me unless there was a gradual release of shares that caused the drop from 164-140. Waiting for a return to normal activity for an entry point as I didn't put in the trade at 145.
massive volume move here
No, This is a trade made today so would be in a subsequent holdings report. Bearing in mind the price now, I'd say it was probably a sale.
10x normal volume already, not sure is this a sale or purchase
well played to those who got in this morning and made 33% in a matter of hours.
FCF might be ****ed in the short term, but considering the addition of pebble beach and the high conversion ratio there should be far more cash than amortized R&D over the coming year(s). The company stated that they upped their R&D this year by >100%, but there is no indication that it will be double again over the course of the next two years so cash should be generated. Also, what is the point in having cash around on the balance sheet (outside of downside protection) if it isn't going to be used to expand the business through acquisitions and new products? They could return it to shareholders but management see better returns in what they are currently pursuing.
31% of Kentz order backlog is in the middle east and the company have been stepping up plans in Iraq over the last few years. I think the ISIS situation in Iraq and general instability is hammering the market cap here, though markets aren't taking into account the opening up of Iran. Totally untapped market for EPC and Oil services.
Is there a hold back on the update of our forecast EPS after the pebblebeach acquisition? Seems we are still valued by brokers at a fwd PE off 12 which was the same as before the acquisition, no?
Everything regresses to the mean over time, this share has been no different. Look at the past performance. I'd rather not buy the rise on the basis that it will go on forever.
I don't doubt that, but it depends how it is done. Either way you like it, there will be a depression of the market as ~£300mil worth of shares are released to onto a free float.
Seems those looking to sell have dried up and buyers are having to pay those who are looking to hold longer term. This is an excellent business with the ability to protect itself from competitors, has history of sustained growth, is able to get a significant return on invested capital, and intends to start using leverage to increase those returns. I have been looking for an entry point for some time and got one on tuesday and will hold for the long term gains.
https://uk.finance.yahoo.com/news/gulf-capital-sell-rest-gms-133511927.html open market sale
I thought gulf capital announced they intended to sell the remaining stake in the open market over the next 18 months?
The move into healthcare has been an interesting one, its adding growth and diversity to the business. It been a a growing part of the business since I invested here and may be undervalued by the w
I'd put these shares at a likely price of 310p in 2015 on a prospective 10x PE multiple. Will build a small position over time and before the RNS for 1H 2014.
I'll wait for a push back to the long term moving averages. Lack of free funds held me back at £3.80 when it was flat.
fell i missed the boat here a few month ago. Will need to wait for a retraction to get in.